Noticias

Taking place on 5 July: New concepts in COPD

junio 27, 2023

Taking place on 5 July, this ERS Vision Live panel discussion will focus on new concepts in chronic obstructive pulmonary disease (COPD).

When GETomics meets aging and exercise in COPD

junio 7, 2023

The term GETomics has been recently proposed to illustrate that human health and disease are actually the final outcome of many dynamic, interacting and cumulative gene environment interactions that occur through the lifetime of the individual.

Global Burden of Diseases Study 2017 and Respiratory diseases

Tackling the global burden of lung disease through prevention and early diagnosis

junio 7, 2023

The Global Burden of Disease Study 2017 identified that a country’s sociodemographic index was a key factor affecting mortality and loss of health from respiratory diseases.

GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists

mayo 26, 2023

COPD is the elephant in the room for many patients with CVDs.

Cluster analyses from the real-world NOVELTY study: six clusters across the asthma-COPD spectrum

mayo 23, 2023

Cluster analyses in NOVELTY patients with asthma and/or COPD yielded identifiable clusters, with several discriminatory features that differed from conventional diagnostic characteristics.

Clinical characteristics of chronic obstructive pulmonary disease in never-smokers: A systematic review

mayo 23, 2023

Chronic Obstructive Pulmonary Disease (COPD) is the third cause of death worldwide. While tobacco smoking is a key risk factor, COPD also occurs in never-smokers (NS).

Alvar Agustì, miembro de la ACADEMIA EUROPAEA

mayo 22, 2023

Alvar Agustí forma parte de la ACADEMIA EUROPAEA desde 2022 por sus numerosas aportaciones en contenido y publicaciones.

XXXV Jornadas Técnicas del Institut Guttmann

mayo 16, 2023

El 21 de junio se celebrará en CaixaFòrum Barcelona las XXXV Jornadas Técnicas del Institut Guttmann. Este año las jornadas están dedicadas a la humanización en la asistencia, con el foco en la neurorrehabilitación

Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19

mayo 9, 2023

1 year after an acute COVID-19 episode, patients with either lung sequelae or long COVID show a stronger SARS-CoV-2-specific T-cell response than fully recovered individuals, suggesting persistent cell stimulation by residual viral reservoirs

ERJ Podcast: GOLD 2023

abril 30, 2023

Chief Editor James Chalmers interviews Alvar Agusti (Hospital Clinic, Barcelona, Spain)about the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) report. Listen it here.

Taking place on 5 July: New concepts in COPD

When GETomics meets aging and exercise in COPD

Tackling the global burden of lung disease through prevention and early diagnosis

GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists

Cluster analyses from the real-world NOVELTY study: six clusters across the asthma-COPD spectrum

Clinical characteristics of chronic obstructive pulmonary disease in never-smokers: A systematic review

Alvar Agustì, miembro de la ACADEMIA EUROPAEA

XXXV Jornadas Técnicas del Institut Guttmann

Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19

ERJ Podcast: GOLD 2023

Cátedra UB de Salud Respiratoria

Recibe avisos de nuevas publicaciones

Legal

2024 © Cátedra UB de Salud Respiratoria. All rights reserved.

Entérate de
Nuestras Publicaciones

Noticias

Cátedra UB de Salud Respiratoria

Recibe avisos de nuevas publicaciones

Legal

2024 © Cátedra UB de Salud Respiratoria. All rights reserved.

Entérate de Nuestras Publicaciones

Entérate de
Nuestras Publicaciones